Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- R-155-100 - Provider product page
- Provider
- Biosensis Pty Ltd
- Proper citation
- Biosensis Cat#R-155-100, RRID:AB_2492957
- Product name
- Rabbit antibody to MAP1LC3 B : whole serum
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- A synthetic peptide (FEQRVEDVRLIC) corresponding to the N-terminal of human MAP1LC3 B protein conjugated to Blue Carrier Protein has been used as the immunogen. The peptide is homologous with the corresponding sequence derived from mouse and rat MAP1LC3 B protein.
- Reactivity
- Human, Rat
- Host
- Rabbit
- Antigen sequence
FEQRVEDVRLIC
- Vial size
- 100 µl
- Storage
- Lyophilised. After reconstitution keep aliquots at -20°C for a higher stability, and at 4°C with an appropriate antibacterial agent. Glycerol (1:1) may be added for an additional stability. Avoid repetitive freeze/thaw cycles.
- Handling
- Reconstitute in 100 µl of sterile water. Centrifuge to remove any insoluble material.
Submitted references Specific protein patterns characterize metastatic potential of advanced bladder cancer.
Pilchowski R, Stöhr R, von Eggeling F, Hartmann A, Wunderlich H, Junker K
The Journal of urology 2011 Aug;186(2):713-20
The Journal of urology 2011 Aug;186(2):713-20
No comments: Submit comment
No validations: Submit validation data